Why is HIV pre-exposure prophylaxis struggling to find a home in UK primary healthcare?

Nathan Burley; Ross Kincaid; Marguerite Ferrier; Andrew Radley; Claudia Estcourt

doi:10.1211/PJ.2025.1.380695

Why is HIV pre-exposure prophylaxis struggling to find a home in UK primary healthcare?

Nathan Burley
, Ross Kincaid
, Marguerite Ferrier
, Andrew Radley
, Claudia Estcourt

Health Sciences

Research output: Contribution to journal › Article › peer-review

16 Downloads (Pure)

Abstract

A team of collaborators discuss the barriers to pre-exposure prophylaxis provision in UK primary care and put forward potential solutions.

Original language	English
Number of pages	10
Journal	Pharmaceutical Journal
Volume	361
Issue number	8002
DOIs	https://doi.org/10.1211/PJ.2025.1.380695
Publication status	Published - 22 Oct 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1211/PJ.2025.1.380695

Author Accepted ManuscriptAccepted author manuscript, 452 KB

Cite this

@article{915ff865d56d45fbb3e06741cf3d1e3b,

title = "Why is HIV pre-exposure prophylaxis struggling to find a home in UK primary healthcare?",

abstract = "A team of collaborators discuss the barriers to pre-exposure prophylaxis provision in UK primary care and put forward potential solutions.",

author = "Nathan Burley and Ross Kincaid and Marguerite Ferrier and Andrew Radley and Claudia Estcourt",

year = "2025",

month = oct,

day = "22",

doi = "10.1211/PJ.2025.1.380695",

language = "English",

volume = "361",

journal = "Pharmaceutical Journal",

issn = "0031-6873",